NON-SMALL CELL LUNG CANCER STAGE IIIA side effect
What is NON-SMALL CELL LUNG CANCER STAGE IIIA ?Drugs associated with NON-SMALL CELL LUNG CANCER STAGE IIIA
REBIFNON-SMALL CELL LUNG CANCER STAGE IIIA : Rebif Side Effects Report #5509429-1
Physician from UNITED STATES reported REBIF problem on Oct 22, 2007. Male patient, 70 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: metastases to lymph nodes, non-small cell lung cancer stage iiia, skin ulcer, . REBIF dosage: unknown. During the same period patient was treated with GLUCOPHAGE ER, PLAVIX, PENTOXIFYLLIN, AMARYL, NEXIUM, ZETIA, FLOMAX, PROPO. Patient recovered.